ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

November 7, 1980

Gallo Publishes Study to Resolve controversy Over HIV Discovery

March 15, 1991

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

West Virginia CCOP Will Be Funded; NASAU Joins Cincinnati As The Two Cut For Slow Patient Accrual

August 31, 1984

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975